NCT03480295View on ClinicalTrials.gov

Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 19, 2016

Primary Completion Date

April 27, 2017

Study Completion Date

April 27, 2017

Conditions
Glaucoma
Interventions
DEVICE

Hyaluronic acid 0.4% and Taurine 0.5%

4 drops /day in addition to the ongoing glaucoma treatment

DEVICE

Hyaluronic acid 0.2%

4 drops /day in addition to the ongoing glaucoma treatment

All Listed Sponsors
lead

Fondazione G.B. Bietti, IRCCS

OTHER

NCT03480295 - Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5% | Biotech Hunter | Biotech Hunter